Icariin inhibits the growth of human cervical cancer cells by inducing apoptosis and autophagy by targeting mTOR/PI3K/AKT signalling pathway.

CONCLUSION: Taken together Icariin may prove potent and efficacious lead molecule for the development of therapy for cervical cancer. PMID: 31424652 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/31424652?dopt=Abstract

Source: Journal of B.U.ON. - August 20, 2019 Category: Cancer & Oncology Tags: J BUON Source Type: research